Trials of Moderna’s COVID-19 vaccine show that it’s safe and effective for teenagers, the company said Tuesday — a finding that could boost supply ahead of the new school year’s start this fall.

“We will submit these results to the U.S. [Food and Drug Administration] and regulators globally in early June and request authorization” for use in kids from age 12 to 17, Moderna CEO Stéphane Bancel said.

The company announced the positive results roughly two weeks after the FDA said children 12 to 15 years old are now eligible to receive the Pfizer-BioNTech vaccine.

Source

Back to Latest